Trial Type: Neuroblastoma (Pediatric)

Neuroblastoma Maintenance Therapy Trial
Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Status: Open
Contact: Bradley Denardo, MD
Phase II Trial of Eflornithine
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Status: Open
Contact: Bradley Denardo, MD